skip to main content
Southern Health NHS Foundation Trust Southern Health Covid-19 Service Changes


Here is a list of some of the publications the Memory Assessment & Research Centre have collaborated on or been involved with:

MARC Publications

  • Wilkinson, D., & Roughan, L., (2007). Special report: The BRAINz trial: A novel approach to acetylcholinesterase inhibitor treatment for Alzheimer’s Disease. Future Neurology, 2 (4): 1-4

  • Perry, H., Cunningham, C., & Holmes, C., (2007). Systemic infections and inflammation affect chronic neurodegeneration. Nature reviews immunology, 7: 161-167

  • Holmes, C., Knights, A., Dean, C., Hodkinson, S., Hopkins, V. (2006). Keep music live: music and the alleviation of apathy in dementia subjects. International Psychogeriatrics. Volume 18, Issue 4, Pages 623-630

  • Holmes, C., Wilkinson, D., Dean, C., Vethanayagam, S., Olivieri, S., Langley, A., Pandita-Gunawardena, N. D., Hogg, F., Clare, C., & Damms, J., (2004). The efficacy of donepezil in the treatment of neuropsychiatric symptoms of Alzheimer disease. Neurology, 63 (2):

  • Wilkinson, D., Stave, C., Keohane, D., & Vincenzino, O. (2004). The role of general practitioners in the diagnosis and treatment of Alzheimer’s Disease: A multinational survey. The Journal of International Medical Research, 32: 149-159

  • Wilkinson, D. & Deas, K., (2007) Is the reduced worsening of clinical symptoms a more realistic expectation of treatment outcome in patients with Alzheimer’s Disease? European Neurological Disease, 2007: 37-39

  • Wilkinson, D. (2005). Review: Is there a double standard when it comes to dementia care? International Journal of Clinical Practice, 59 (146): 3-7

  • Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O., (2003). Neuropathology of human Alzheimer Disease after immunization with amyloid-β peptide: a case report. Nature Medicine, 9 (4): 448-452

  • McKeith, I., O’Brien, J., Walker, Z., Tatsch, K., Booij, J., Darcourt, J., Padovani, A., Giubbini, R., Bonuccelli, U., Volterrani, D., Holmes, C., Kemp, P., Tabet, N., Meyer, I., & Reininger, C., (2007). Sensitivity and specificity of dopamine transporter imaging with I-FP-CIT SPECT in dementia with Lewy Bodies: A phase III, multicentre study. Lancet Neurology, 6, 305-313

  • Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R. W., Bullock, R., Love S., Neal, J. W., Zotova, E., & Nicoll, J. A. R., (2008). Long-term effects of Aβ immunisation in Alzheimer’s Disease: Follow-up of a randomised, placebo-controlled phase I trial. Lancet, 37 (2): 216-23

  • Homes, C., Hopkins, V., Hensford, C., MacLaughlin, V., Wilkinson, D., & Rosenvinge, H., (2002) Lavender oil as a treatment for agitated behaviour in severe dementia: A placebo controlled study. International Journal of Geriatric Psychiatry, 17: 305-308

  • Boche, D., Zotova, E., Weller, R. O., Love, S., Neal, J. W., Pickering, R. M., Wilkinson, D., Holmes, C., & Nicoll, J. A. R., (2008). Consequence of Aβ immunization on the vasculature of human Alzheimer’s Disease brain. Brain, 131: 3299-3310

MARC logo.jpg
Page Comments